Article
Immune endotypes in tuberculosis: Keys to decoding disease complexity.
Journal of internal medicine - 1 Jun 2026
Alipoor Shamila D, Guthrie Julia, Forsman Lina Davies, Di Nardo Andrew R, Brighenti Susanna
Abstract excerpt
Tuberculosis (TB) remains a major global health challenge, with multi-drug antibiotic regimens as the current standard of care. While effective at killing Mycobacterium tuberculosis, these treatments do not resolve persistent inflammation, prevent lung damage, or reverse immune dysregulation that contribute to poor outcomes and disease recurrence. Precision medicine offers a promising alternative but requires...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
